Effect of maintenance bolus on the recovery profile of a short-acting nondepolarizing muscle relaxant

2002 ◽  
Vol 14 (7) ◽  
pp. 500-504
Author(s):  
Xiaoguang Chen ◽  
Jun Tang ◽  
Paul F White ◽  
Ronald H Wender ◽  
Alexander Sloninsky ◽  
...  
Keyword(s):  
Muscle Relaxant ◽  
Short Acting ◽  
Recovery Profile ◽  
Nondepolarizing Muscle Relaxant

The Effect of Small Dose of Nondepolarizing Muscle Relaxant Administered Prior to Succinylcholine on Intubating Condition

1993 ◽  
Vol 26 (1) ◽  
pp. 50
Author(s):  
Jin Seung Lee ◽  
Jang Weon Lee ◽  
Si Young Ok ◽  
Yoo Jae Kim ◽  
Wook Park ◽  
...  
Keyword(s):  
Muscle Relaxant ◽  
Small Dose ◽  
Nondepolarizing Muscle Relaxant

Clinical Signs with Modified Electroconvulsive Therapy

1963 ◽  
Vol 109 (460) ◽  
pp. 399-403 ◽  
Author(s):  
J. G. Whitwam ◽  
T. Moreton ◽  
J. Norman
Keyword(s):  
Electroconvulsive Therapy ◽  
Muscle Relaxant ◽  
Parasympathetic Nervous System ◽  
Clinical Signs ◽  
Short Acting ◽  
Neurological Signs ◽  
Clinical Description ◽  
Modified Electroconvulsive Therapy ◽  
Acting Muscle ◽  
Stimulation Of

In many electroconvulsive therapy centres atropine is used to mitigate adverse effects resulting from stimulation of the parasympathetic nervous system, while the violence of muscular contractions is controlled with a muscle relaxant. It is customary to secure hypnosis with a short acting barbiturate prior to administration of the relaxant. The first report of the use of thiopentone for E.C.T. was by Rubinstein (1945), and methohexitone (Lilly 25398) was introduced by Friedman (1959). The use of succinylcholine (iodide) for E.C.T. was first reported by Holmberg and Thesleff (1951). The neurological signs during unmodified E.C.T. have been well documented (e.g. Klein and Early, 1948a, 1948b, 1949; Kalinowsky and Hoch, 1952). There is as yet no comparable detailed clinical description of E.C.T. when modified by atropine and a short acting muscle relaxant preceded by a barbiturate. This discussion is limited to some of those signs which may be of assistance in the management of therapy.

VASCULAR EFFECTS OF ORG9487 IN HUMAN MAMMARY ARTERIES, A NEW SHORT ACTING MUSCLE RELAXANT

1998 ◽  
Vol 86 (Supplement) ◽  
pp. 109SCA
Author(s):  
K Yamaguchi ◽  
C Huraux ◽  
F Szlam ◽  
JH Levy
Keyword(s):  
Muscle Relaxant ◽  
Vascular Effects ◽  
Short Acting ◽  
Mammary Arteries ◽  
Acting Muscle

Some actions of chandonium iodide, a new short-acting muscle relaxant, in anaesthetized cats and on isolated muscle preparations

1975 ◽  
Vol 2 (2) ◽  
pp. 159-170 ◽  
Author(s):  
A. Gandiha ◽  
I. G. Marshall ◽  
D. Paul ◽  
I. W. Rodger ◽  
W. Scott ◽  
...  
Keyword(s):  
Muscle Relaxant ◽  
Short Acting ◽  
Acting Muscle
Sign in / Sign up

Export Citation Format

Share Document